11 Feb Update on acquisition of Primerdesign Ltd
Posted at 15:32h
in Novacyt Group
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, updates the market on its intended acquisition of Primerdesign Ltd (“Primerdesign”), a profitable and rapidly growing UK molecular diagnostics company.